• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND UNK-CV-SR; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND UNK-CV-SR; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stroke/CVA (1770); Ischemia (1942); Pain (1994); Paralysis (1997); Rupture (2208); Stenosis (2263); Vascular Dissection (3160)
Event Date 10/18/2022
Event Type  Injury  
Manufacturer Narrative
Medtronic received the following information obtained from the journal article entitled: management of left subclavian artery in type b aortic dissection treated with thoracic endovascular aorta repair wang et al, journal of vascular surgery, volume 77, issue 5, p1553-1561.E2, doi:https://doi.Org/10.1016/j.Jvs.2022.10.013 a2: mean age a3: mean gender d6a: exact date of implant unknown date of publish used for incident date in section b;3 there was no information to suggest any medtronic device failure caused or contributed to a death.Deaths are common occurrences however the cause(s) of death are often not characterized or clearly associated with a particular product.Therefore, deaths will not be considered reportable as mdr unless clearly stated as being associated with medtronic product.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event Description
Medtronic stent grafts (unknown type) were implanted during the endovascular treatment of type b thoracic aortic dissections on unknown dates.Non medtronic grafts were also used.The following adverse events were reported: dissection, steal syndrome, left arm claudication.Stroke, paraplegia, spinal cord ischemia, aortic rupture, reintervention and death.The cause of the adverse events are undetermined.There was no information to suggest any medtronic device failure caused or contrib uted to a death.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNK-CV-SR
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
EI 
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
EI  
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key19212302
MDR Text Key341372685
Report Number9612164-2024-02060
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeSZ
PMA/PMN Number
P100040
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 04/30/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/24/2024
Initial Date FDA Received04/30/2024
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age57 YR
-
-